Related references
Note: Only part of the references are listed.A Five-Gene Signature Associated With DNA Damage Repair Molecular Subtype Predict Overall Survival for Hepatocellular Carcinoma
Junyu Huo et al.
FRONTIERS IN GENETICS (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
3,3′-Diindolylmethane Promotes Gastric Cancer Progression via β-TrCP-Mediated NF-κB Activation in Gastric Cancer-Derived MSCs
Hui Shi et al.
FRONTIERS IN ONCOLOGY (2021)
Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions
Justin M. Hansen et al.
CELL (2021)
Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures
Xinke Zhang et al.
FRONTIERS IN IMMUNOLOGY (2021)
Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
Chengxing Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Cullin 7 in tumor development: a novel potential anti-cancer target
Yumiao Li et al.
NEOPLASMA (2021)
Colorectal cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability
Dustin R. Long et al.
CLINICAL CHEMISTRY (2020)
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Aurelien Marabelle et al.
LANCET ONCOLOGY (2020)
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
CUL7 promotes cancer cell survival through promoting Caspase-8 ubiquitination
Yanjie Kong et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Matthew D. Hellmann et al.
CANCER CELL (2018)
Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics
Shagufta Shafique et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
M. D. Hellmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Systemic Therapy for Colon Cancer
Christina Wu
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
A history of exploring cancer in context
Shelly Maman et al.
NATURE REVIEWS CANCER (2018)
Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer
Min Sun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Factors influencing treatment selection and survival in advanced lung cancer
S. Tabchi et al.
CURRENT ONCOLOGY (2017)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Biomarker: Predictive or Prognostic?
Karla V. Ballman
JOURNAL OF CLINICAL ONCOLOGY (2015)
Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients
J. Zhan et al.
BRITISH JOURNAL OF CANCER (2014)
The CUL7/F-box and WD Repeat Domain Containing 8 (CUL7/Fbxw8) Ubiquitin Ligase Promotes Degradation of Hematopoietic Progenitor Kinase 1
Hua Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
From human genome to cancer genome: The first decade
David A. Wheeler et al.
GENOME RESEARCH (2013)
Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome
Valerie Paradis et al.
GUT (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
Srividya Swaminathan et al.
NATURE MEDICINE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
CD2AP/SHIP1 Complex Positively Regulates Plasmacytoid Dendritic Cell Receptor Signaling by Inhibiting the E3 Ubiquitin Ligase Cbl
Musheng Bao et al.
JOURNAL OF IMMUNOLOGY (2012)
BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs
Rebecca Mathew et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma
Siok-Bian Ng et al.
BLOOD (2011)
Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma
Nicholas J. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Nicolas Stransky et al.
SCIENCE (2011)
Microsatellite Instability in Colorectal Cancer
C. Richard Boland et al.
GASTROENTEROLOGY (2010)
Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma
Aaron J. Schetter et al.
CLINICAL CANCER RESEARCH (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Induction of Cullin 7 by DNA damage attenuates p53 function
Peter Jung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A Critical Role for FBXW8 and MAPK in Cyclin D1 Degradation and Cancer Cell Proliferation
Hiroshi Okabe et al.
PLOS ONE (2006)
CUL7:: A DOC domain-containing cullin selectively binds Skp1•Fbx29 to form an SCF-like complex
DC Dias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
